--- title: "Viatris Inc Recalls: Agency-Reported Status and History (Oct 1, 2026) | Is It on Recall" description: "Search Viatris Inc recall records, lots, firms and dates. Reported status can be incomplete; use the linked agency notice for current instructions." url: https://isitonrecall.com/brand/viatris-inc/ updated: 2026-10-01 site: "Is It on Recall" language: en --- [Home](https://isitonrecall.com/) / Brand archive # Viatris Inc recall records **12** reported ongoing 23 records in this archive. Latest source date Mar 17, 2026. FDA enforcement status can lag behind the recall lifecycle. An empty search or a reported termination is not a personal product-safety determination. Archive changed Oct 1, 2026. USDA FSIS records are unavailable; [check FSIS directly](https://www.fsis.usda.gov/recalls). [Source coverage and dates](https://isitonrecall.com/sources/). ## Records and reported status Mar 17, 2026 FDA drug enforcement ### [Xanax XR, alprazolam, extended-release tablets, 3 mg, 60 Tablets bottles, Rx only, Distributed by: Viatris Specialty LLC, Morgantown, WV 06506, U.S.A, Made in Ireland, NDC 58151...](https://isitonrecall.com/recall/fda-drug-d-0444-2026-xanax-xr-alprazolam-extended-release-tablets-3-mg-60-tablets-bottles-rx-only-distributed-by-viatris/) Failed Dissolution Specifications Class II Reported ongoing Distribution: US Nationwide. [Official source for Xanax XR, alprazolam, extended-release tablets, 3 mg, 60 Tablets bottles, Rx only, Distributed by...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0444-2026%22) Dec 23, 2024 FDA drug enforcement ### [Cardura XL (doxazosin) extended release tablets 8 mg, 30-count bottle, Rx only, Distributed by Viatris Specialty LLC, Morgantown, WV 26505, NDC 58151-079-93](https://isitonrecall.com/recall/fda-drug-d-0203-2025-cardura-xl-doxazosin-extended-release-tablets-8-mg-30-count-bottle-rx-only-distributed-by-viatris-sp/) Failed Impurities/Degradation Specifications: Out of specification results observed for the impurity compound B during stability testing. Class II Reported terminated Distribution: USA nationwide. [Official source for Cardura XL (doxazosin) extended release tablets 8 mg, 30-count bottle, Rx only, Distributed by Vi...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0203-2025%22) Dec 23, 2024 FDA drug enforcement ### [Cardura XL (doxazosin) extended release tablets 4 mg, 30 -count bottle, Rx only, Distributed by Viatris Specialty LLC, Morgantown, WV 26505, NDC 58151-078-93](https://isitonrecall.com/recall/fda-drug-d-0204-2025-cardura-xl-doxazosin-extended-release-tablets-4-mg-30-count-bottle-rx-only-distributed-by-viatris-sp/) Failed Impurities/Degradation Specifications: Out of specification results observed for the impurity compound B during stability testing. Class II Reported terminated Distribution: USA nationwide. [Official source for Cardura XL (doxazosin) extended release tablets 4 mg, 30 -count bottle, Rx only, Distributed by V...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0204-2025%22) Nov 18, 2024 FDA drug enforcement ### [Levothyroxine Sodium Tablets USP, 125 mcg, packaged in a) 90-count bottles (NDC 0378-1813-77) and b) 1000-count bottles (NDC 0378-1813-10), Rx only, Manufactured for: Mylan Phar...](https://isitonrecall.com/recall/fda-drug-d-0118-2025-levothyroxine-sodium-tablets-usp-125-mcg-packaged-in-a-90-count-bottles-ndc-0378-1813-77-and-b-1000/) Superpotent Drug and Subpotent Drug: potency failures obtained Class II Reported ongoing Distribution: Nationwide within the United States and Puerto Rico [Official source for Levothyroxine Sodium Tablets USP, 125 mcg, packaged in a) 90-count bottles (NDC 0378-1813-77) and...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0118-2025%22) Nov 18, 2024 FDA drug enforcement ### [Levothyroxine Sodium Tablets USP, 137 mcg, packaged in a) 90-count bottles (NDC 0378-1823-77) and b) 1000-count bottles (NDC 0378-1823-10), Rx only, Manufactured for: Mylan Phar...](https://isitonrecall.com/recall/fda-drug-d-0119-2025-levothyroxine-sodium-tablets-usp-137-mcg-packaged-in-a-90-count-bottles-ndc-0378-1823-77-and-b-1000/) Superpotent Drug and Subpotent Drug: potency failures obtained Class II Reported ongoing Distribution: Nationwide within the United States and Puerto Rico [Official source for Levothyroxine Sodium Tablets USP, 137 mcg, packaged in a) 90-count bottles (NDC 0378-1823-77) and...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0119-2025%22) Nov 18, 2024 FDA drug enforcement ### [Levothyroxine Sodium Tablets USP, 150 mcg, packaged in a) 90-count bottles (NDC 0378-1815-77) and b) 1000-count bottles (NDC 0378-1815-10), Rx only, Manufactured for: Mylan Phar...](https://isitonrecall.com/recall/fda-drug-d-0120-2025-levothyroxine-sodium-tablets-usp-150-mcg-packaged-in-a-90-count-bottles-ndc-0378-1815-77-and-b-1000/) Superpotent Drug and Subpotent Drug: potency failures obtained Class II Reported ongoing Distribution: Nationwide within the United States and Puerto Rico [Official source for Levothyroxine Sodium Tablets USP, 150 mcg, packaged in a) 90-count bottles (NDC 0378-1815-77) and...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0120-2025%22) Nov 18, 2024 FDA drug enforcement ### [Levothyroxine Sodium Tablets USP, 175 mcg, packaged in a) 90-count bottles (NDC 0378-1817-77) and b) 1000-count bottles (NDC 0378-1817-10), Rx only, Manufactured for: Mylan Phar...](https://isitonrecall.com/recall/fda-drug-d-0121-2025-levothyroxine-sodium-tablets-usp-175-mcg-packaged-in-a-90-count-bottles-ndc-0378-1817-77-and-b-1000/) Superpotent Drug and Subpotent Drug: potency failures obtained Class II Reported ongoing Distribution: Nationwide within the United States and Puerto Rico [Official source for Levothyroxine Sodium Tablets USP, 175 mcg, packaged in a) 90-count bottles (NDC 0378-1817-77) and...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0121-2025%22) Nov 18, 2024 FDA drug enforcement ### [Levothyroxine Sodium Tablets USP, 200 mcg, packaged in a) 90-count bottles (NDC 0378-1819-77) and b) 1000-count bottles (NDC 0378-1819-10), Rx only, Manufactured for: Mylan Phar...](https://isitonrecall.com/recall/fda-drug-d-0122-2025-levothyroxine-sodium-tablets-usp-200-mcg-packaged-in-a-90-count-bottles-ndc-0378-1819-77-and-b-1000/) Superpotent Drug and Subpotent Drug: potency failures obtained Class II Reported ongoing Distribution: Nationwide within the United States and Puerto Rico [Official source for Levothyroxine Sodium Tablets USP, 200 mcg, packaged in a) 90-count bottles (NDC 0378-1819-77) and...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0122-2025%22) Nov 18, 2024 FDA drug enforcement ### [Levothyroxine Sodium Tablets USP, 25 mcg, packaged in a) 90-count bottles (NDC 0378-1800-77) and b) 1000-count bottles (NDC 0378-1800-10), Rx only, Manufactured for: Mylan Pharm...](https://isitonrecall.com/recall/fda-drug-d-0123-2025-levothyroxine-sodium-tablets-usp-25-mcg-packaged-in-a-90-count-bottles-ndc-0378-1800-77-and-b-1000-c/) Superpotent Drug and Subpotent Drug: potency failures obtained Class II Reported ongoing Distribution: Nationwide within the United States and Puerto Rico [Official source for Levothyroxine Sodium Tablets USP, 25 mcg, packaged in a) 90-count bottles (NDC 0378-1800-77) and ...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0123-2025%22) Nov 18, 2024 FDA drug enforcement ### [Levothyroxine Sodium Tablets USP, 50 mcg, packaged in a) 90-count bottles (NDC 0378-1803-77) and b) 1000-count bottles (NDC 0378-1803-10), Rx only, Manufactured for: Mylan Pharm...](https://isitonrecall.com/recall/fda-drug-d-0124-2025-levothyroxine-sodium-tablets-usp-50-mcg-packaged-in-a-90-count-bottles-ndc-0378-1803-77-and-b-1000-c/) Superpotent Drug and Subpotent Drug: potency failures obtained Class II Reported ongoing Distribution: Nationwide within the United States and Puerto Rico [Official source for Levothyroxine Sodium Tablets USP, 50 mcg, packaged in a) 90-count bottles (NDC 0378-1803-77) and ...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0124-2025%22) Nov 18, 2024 FDA drug enforcement ### [Levothyroxine Sodium Tablets USP, 75 mcg, packaged in a) 90-count bottles (NDC 0378-1805-77) and b) 1000-count bottles (NDC 0378-1805-10), Rx only, Manufactured for: Mylan Pharm...](https://isitonrecall.com/recall/fda-drug-d-0125-2025-levothyroxine-sodium-tablets-usp-75-mcg-packaged-in-a-90-count-bottles-ndc-0378-1805-77-and-b-1000-c/) Superpotent Drug and Subpotent Drug: potency failures obtained Class II Reported ongoing Distribution: Nationwide within the United States and Puerto Rico [Official source for Levothyroxine Sodium Tablets USP, 75 mcg, packaged in a) 90-count bottles (NDC 0378-1805-77) and ...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0125-2025%22) Nov 18, 2024 FDA drug enforcement ### [Levothyroxine Sodium Tablets USP, 88 mcg, packaged in a) 90-count bottles (NDC 0378-1807-77) and b) 1000-count bottles (NDC 0378-1807-10), Rx only, Manufactured for: Mylan Pharm...](https://isitonrecall.com/recall/fda-drug-d-0126-2025-levothyroxine-sodium-tablets-usp-88-mcg-packaged-in-a-90-count-bottles-ndc-0378-1807-77-and-b-1000-c/) Superpotent Drug and Subpotent Drug: potency failures obtained Class II Reported ongoing Distribution: Nationwide within the United States and Puerto Rico [Official source for Levothyroxine Sodium Tablets USP, 88 mcg, packaged in a) 90-count bottles (NDC 0378-1807-77) and ...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0126-2025%22) Nov 18, 2024 FDA drug enforcement ### [Levothyroxine Sodium Tablets USP, 100 mcg, packaged in a) 90-count bottles (NDC 0378-1809-77) and b) 1000-count bottles (NDC 0378-1809-10), Rx only, Manufactured for: Mylan Phar...](https://isitonrecall.com/recall/fda-drug-d-0127-2025-levothyroxine-sodium-tablets-usp-100-mcg-packaged-in-a-90-count-bottles-ndc-0378-1809-77-and-b-1000/) Superpotent Drug and Subpotent Drug: potency failures obtained Class II Reported ongoing Distribution: Nationwide within the United States and Puerto Rico [Official source for Levothyroxine Sodium Tablets USP, 100 mcg, packaged in a) 90-count bottles (NDC 0378-1809-77) and...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0127-2025%22) Nov 18, 2024 FDA drug enforcement ### [Levothyroxine Sodium Tablets USP, 112 mcg, packaged in a) 90-count bottles (NDC 0378-1811-77) and b) 1000-count bottles (NDC 0378-1811-10), Rx only, Manufactured for: Mylan Phar...](https://isitonrecall.com/recall/fda-drug-d-0128-2025-levothyroxine-sodium-tablets-usp-112-mcg-packaged-in-a-90-count-bottles-ndc-0378-1811-77-and-b-1000/) Superpotent Drug and Subpotent Drug: potency failures obtained Class II Reported ongoing Distribution: Nationwide within the United States and Puerto Rico [Official source for Levothyroxine Sodium Tablets USP, 112 mcg, packaged in a) 90-count bottles (NDC 0378-1811-77) and...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0128-2025%22) Apr 30, 2024 FDA drug enforcement ### [Cardura XL (doxazosin) extended release tablets 4mg, 30-count bottles, Rx Only, Made in Singapore, Distributed by Roerig Division of Pfizer Inc, NY, NY 10017 NDC 0049-2040-10](https://isitonrecall.com/recall/fda-drug-d-0602-2024-cardura-xl-doxazosin-extended-release-tablets-4mg-30-count-bottles-rx-only-made-in-singapore-distrib/) Failed Impurities/Degradation Specifications Class II Reported completed Distribution: U.S. Nationwide [Official source for Cardura XL (doxazosin) extended release tablets 4mg, 30-count bottles, Rx Only, Made in Singapore...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0602-2024%22) Apr 30, 2024 FDA drug enforcement ### [Cardura XL (doxazosin) extended release tablets 8mg, 30-count bottles, Rx Only Made in Singapore, Distributed by Roerig Division of Pfizer Inc, NY, NY 10017 NDC 0049-2080-10](https://isitonrecall.com/recall/fda-drug-d-0603-2024-cardura-xl-doxazosin-extended-release-tablets-8mg-30-count-bottles-rx-only-made-in-singapore-distrib/) Failed Impurities/Degradation Specifications Class II Reported completed Distribution: U.S. Nationwide [Official source for Cardura XL (doxazosin) extended release tablets 8mg, 30-count bottles, Rx Only Made in Singapore,...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0603-2024%22) Apr 25, 2024 FDA drug enforcement ### [Valacyclovir Tablets USP, 500 mg, 90 count bottles, Rx Only, Manufactured for: Mylan Pharmaceuticals Inc. Morgantown, WV 26505 USA, NDC 0378-4275-77](https://isitonrecall.com/recall/fda-drug-d-0481-2024-valacyclovir-tablets-usp-500-mg-90-count-bottles-rx-only-manufactured-for-mylan-pharmaceuticals-inc/) Failed Tablet/Capsule Specifications: There is a potential for the imprint, M 122, to be missing on some tablets. Class III Reported completed Distribution: Nationwide within the united states [Official source for Valacyclovir Tablets USP, 500 mg, 90 count bottles, Rx Only, Manufactured for: Mylan Pharmaceutic...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0481-2024%22) May 25, 2023 FDA drug enforcement ### [Levsin injection (hyoscyamine sulfate injection, USP), 0.5 mg per ml in water for Injection, 1 ml Ampule (Box of 5 ampules), Rx Only, Distributed by: Meda pharmaceuticals Inc. (...](https://isitonrecall.com/recall/fda-drug-d-0866-2023-levsin-injection-hyoscyamine-sulfate-injection-usp-0-5-mg-per-ml-in-water-for-injection-1-ml-ampule/) CGMP Deviations: Discontinuation of the Quality program by manufacturer that would assure product meet the identity, strength, quality, and purity characteristics that they are purported or represented to possess. Class II Reported terminated Distribution: Product was distributed to 10 distributors who may have further distribute the product to the retail level. [Official source for Levsin injection (hyoscyamine sulfate injection, USP), 0.5 mg per ml in water for Injection, 1 ml...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0866-2023%22) Oct 21, 2022 FDA drug enforcement ### [Carvedilol Tablets, USP, 25 mg, 500-count bottles, Rx Only, Mfg: Mylan Pharmaceuticals Inc. Morgantown, WV 36505, Made in India, NDC 0378-3634-05](https://isitonrecall.com/recall/fda-drug-d-0063-2023-carvedilol-tablets-usp-25-mg-500-count-bottles-rx-only-mfg-mylan-pharmaceuticals-inc-morgantown-wv-3/) Failed Tablet/Capsule Specifications: Tablets exceeds specification for weight and thickness. Class II Reported terminated Distribution: Nationwide in the USA [Official source for Carvedilol Tablets, USP, 25 mg, 500-count bottles, Rx Only, Mfg: Mylan Pharmaceuticals Inc. Morga...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0063-2023%22) Oct 7, 2022 FDA drug enforcement ### [Octreotide Acetate Injection 500 mcg/mL, 10 x 1 mL Single-Dose Unit-of-Use Syringes, For Subcutaneous or Intravenous Use, Rx Only, Manufactured for: Mylan Institutional LLC, Mor...](https://isitonrecall.com/recall/fda-drug-d-0058-2023-octreotide-acetate-injection-500-mcg-ml-10-x-1-ml-single-dose-unit-of-use-syringes-for-subcutaneous/) Presence of Particulate Matter: Product complaint for the presence of glass particles in a syringe. Class I Reported terminated Distribution: Nationwide in the USA [Official source for Octreotide Acetate Injection 500 mcg/mL, 10 x 1 mL Single-Dose Unit-of-Use Syringes, For Subcutan...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0058-2023%22) ## Reasons in these listed records - Failed Dissolution Specifications - Failed Impurities/Degradation Specifications: Out of specification results observed for the impurity compound B during stability testing. - Superpotent Drug and Subpotent Drug: potency failures obtained - Failed Impurities/Degradation Specifications These examples come from this result page and are not a ranking of every recall reason. ## Checking Viatris Inc ### Is there a recall on viatris inc right now? This archive contains 23 records, including 12 with agency-reported ongoing status. The status field can be incomplete or stale. Open the current official notice and match your exact product. ### How do I check my package or product? Compare the product, firm and lot, date, model or serial identifiers with the notice. [Use the label-check guide](https://isitonrecall.com/guides/read-lot-codes/) if you need help locating an identifier. ### Does a matching name mean every item is included? A name is a search match. The agency notice sets the affected products and identifiers. Do not assume that every item with the same name or brand belongs to the recall. ### What if the search finds no matching record? This search has source and keyword limits. Missing records or a missing lot code do not establish that a product is unaffected. [Check source coverage](https://isitonrecall.com/sources/) and the agency's current notices. ### Where can I find older records? Use [monthly archives](https://isitonrecall.com/archives/) or the local search. The initial import covers records dated from October 2021 where available; each source's actual first and latest dates appear on the coverage page. ## Keep checking [Search Viatris Inc](https://isitonrecall.com/check/?q=Viatris%20Inc) [Browse related products](https://isitonrecall.com/products/) [Review source dates](https://isitonrecall.com/sources/)